5-(Quinolin-3-yl)naphtho[2,3-b]pyrrolo[1,2-d][1,4]oxazepin-4-yl acetate

ID: ALA4445713

Chembl Id: CHEMBL4445713

PubChem CID: 155517753

Max Phase: Preclinical

Molecular Formula: C27H18N2O3

Molecular Weight: 418.45

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC(=O)OC1=C(c2cnc3ccccc3c2)Oc2cc3ccccc3cc2-n2cccc21

Standard InChI:  InChI=1S/C27H18N2O3/c1-17(30)31-27-23-11-6-12-29(23)24-14-18-7-2-3-8-19(18)15-25(24)32-26(27)21-13-20-9-4-5-10-22(20)28-16-21/h2-16H,1H3

Standard InChI Key:  KBEHTEGCAHJHQJ-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4445713

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 418.45

Molecular Weight (Monoisotopic): 418.1317

AlogP: 5.96

#Rotatable Bonds: 2

Polar Surface Area: 53.35

Molecular Species: NEUTRAL

HBA: 5

HBD: 0

#RO5 Violations: 1

HBA (Lipinski): 5

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 1

CX Acidic pKa:

CX Basic pKa: 3.45

CX LogP: 4.58

CX LogD: 4.58

Aromatic Rings: 5

Heavy Atoms: 32

QED Weighted: 0.33

Np Likeness Score: -0.18

References

1. Brindisi M, Ulivieri C, Alfano G, Gemma S, de Asís Balaguer F, Khan T, Grillo A, Chemi G, Menchon G, Prota AE, Olieric N, Lucena-Agell D, Barasoain I, Diaz JF, Nebbioso A, Conte M, Lopresti L, Magnano S, Amet R, Kinsella P, Zisterer DM, Ibrahim O, O'Sullivan J, Morbidelli L, Spaccapelo R, Baldari C, Butini S, Novellino E, Campiani G, Altucci L, Steinmetz MO, Brogi S..  (2019)  Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents.,  162  [PMID:30448418] [10.1016/j.ejmech.2018.11.004]

Source

Source(1):

• Scientific Literature